{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:01:47Z","timestamp":1726848107064},"reference-count":36,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.04.034","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T22:56:33Z","timestamp":1335221793000},"page":"4023-4027","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Julie A.","family":"Bettinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Scheifele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otto G.","family":"Vanderkooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Schryvers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joenel","family":"Alcantara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (ACS-3)","key":"10.1016\/j.vaccine.2012.04.034_bib0005","first-page":"1","article-title":"Statement on conjugate meningococcal vaccine for serogroups A, C, Y and W135. An Advisory Committee Statement (ACS)","volume":"33","year":"2007","journal-title":"Canada Communicable Disease Report"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2012.04.034_bib0010","first-page":"17","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001","volume":"30","author":"Squires","year":"2004","journal-title":"Canada Communicable Disease Report"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.04.034_bib0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3201\/eid0805.010337","article-title":"Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada","volume":"8","author":"Tyrrell","year":"2002","journal-title":"Emerging Infectious Diseases"},{"issue":"June (10)","key":"10.1016\/j.vaccine.2012.04.034_bib0020","first-page":"1","article-title":"Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005","volume":"33","year":"2007","journal-title":"Canada Communicable Disease Report"},{"issue":"October (AC 6)","key":"10.1016\/j.vaccine.2012.04.034_bib0025","first-page":"2","article-title":"An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines","volume":"27","year":"2001","journal-title":"Canada Communicable Disease Report"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2012.04.034_bib0030","first-page":"1520","article-title":"Quebec's $100-million campaign targets meningococcal disease","volume":"165","author":"Pinker","year":"2001","journal-title":"CMAJ: Canadian Medical Association Journal"},{"key":"10.1016\/j.vaccine.2012.04.034_bib0035","unstructured":"Publicly funded Immunization Programs in Canada \u2013 Routine Schedule for Infants and Children including special programs and catch-up programs, 2011 July 7; 2011 [cited 2011 August 10]. Available from: http:\/\/www.phac-aspc.gc.ca\/im\/ptimprog-progimpt\/table-1-eng.php."},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.04.034_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/INF.0b013e3181f728fd","article-title":"Persistence of immunity following a booster dose of Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial","volume":"30","author":"Khatami","year":"2011","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.04.034_bib0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clinical and Vaccine Immunology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.04.034_bib0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide\u2013protein conjugate vaccine","volume":"24","author":"Snape","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.04.034_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/j.vaccine.2012.04.034_bib0060","series-title":"Requirements for meningococcal polysaccharide vaccine","year":"1976"},{"key":"10.1016\/j.vaccine.2012.04.034_bib0065","series-title":"Recommendations for the production and control of meningococcal group C conjugate vaccine","year":"2004"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2012.04.034_bib0070","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2012.04.034_bib0075","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection \u2013 serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.04.034_bib0080","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CVI.00529-09","article-title":"Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity","volume":"17","author":"Campbell","year":"2010","journal-title":"Clinical and Vaccine Immunology"},{"issue":"July (32)","key":"10.1016\/j.vaccine.2012.04.034_bib0085","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"issue":"July (9431)","key":"10.1016\/j.vaccine.2012.04.034_bib0090","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.04.034_bib0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/INF.0b013e31816b4561","volume":"27","author":"Tejedor","year":"2008","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.vaccine.2012.04.034_bib0100","unstructured":"Vancouver, British Columbia (Code933) (table). 2006 Community Profiles 2006 Census Statistics Canada Catalogue no. 92-591-XWE 2007 [cited 2012 January 26]. Available from: http:\/\/www12.statcan.ca\/census-recensement\/2006\/dp-pd\/prof\/92-591\/index.cfm?Lang=E."},{"key":"10.1016\/j.vaccine.2012.04.034_bib0105","unstructured":"Halifax, Nova Scotia (Code205) (table). 2006 Community Profiles 2006 Census Statistics Canada Catalogue no. 92-591-XWE 2007 [cited 2012 January 26]. Available from: http:\/\/www12.statcan.ca\/census-recensement\/2006\/dp-pd\/prof\/92-591\/index.cfm?Lang=E."},{"key":"10.1016\/j.vaccine.2012.04.034_bib0110","unstructured":"Calgary, Alberta (Code825) (table). 2006 Community Profiles 2006 Census Statistics Canada Catalogue no. 92-591-XWE 2007 [cited 2012 January 26]. Available from: http:\/\/www12.statcan.ca\/census-recensement\/2006\/dp-pd\/prof\/92-591\/index.cfm?Lang=E."},{"issue":"July (1)","key":"10.1016\/j.vaccine.2012.04.034_bib0115","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/aje\/kwi160","article-title":"Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination","volume":"162","author":"Trotter","year":"2005","journal-title":"American Journal of Epidemiology"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.04.034_bib0120","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs","volume":"8","author":"Trotter","year":"2009","journal-title":"Expert Review of Vaccines"},{"issue":"October (7)","key":"10.1016\/j.vaccine.2012.04.034_bib0125","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/infdis\/jir466","article-title":"Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation","volume":"204","author":"Ibarz-Pavon","year":"2011","journal-title":"The Journal of Infectious Diseases"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2012.04.034_bib0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"The Journal of Infectious Diseases"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.04.034_bib0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00006454-200102000-00007","article-title":"Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants","volume":"20","author":"Rennels","year":"2001","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"June (25)","key":"10.1016\/j.vaccine.2012.04.034_bib0140","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1016\/j.vaccine.2011.03.009","article-title":"An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix hexa is immunogenic, with an acceptable safety profile in 12\u201323-month-old children","volume":"29","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"issue":"March (11\u201312)","key":"10.1016\/j.vaccine.2012.04.034_bib0145","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0264-410X(02)00630-8","article-title":"Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era","volume":"21","author":"Trotter","year":"2003","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.04.034_bib0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/INF.0b013e3181b9a831","article-title":"A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months","volume":"29","author":"Diez-Domingo","year":"2010","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.04.034_bib0155","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infection and Immunity"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2012.04.034_bib0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/INF.0b013e3181d9e653","article-title":"Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life","volume":"29","author":"Diez-Domingo","year":"2010","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.04.034_bib0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1086\/317646","article-title":"Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers","volume":"183","author":"Richmond","year":"2001","journal-title":"The Journal of Infectious Diseases"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2012.04.034_bib0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein\u2013polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nature Reviews Immunology"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2012.04.034_bib0175","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999\u20132000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2012.04.034_bib0180","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom","volume":"186","author":"Borrow","year":"2002","journal-title":"The Journal of Infectious Diseases"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12005658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:38:43Z","timestamp":1594035523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12005658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":36,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X12005658"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}